Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.
about
Emerging treatment strategies for glioblastoma multiformeLessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma PatientsPerfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.Assessment of early response to tumor-treating fields in newly diagnosed glioblastoma using physiologic and metabolic MRI: initial experience.Early Biomarkers from Conventional and Delayed-Contrast MRI to Predict the Response to Bevacizumab in Recurrent High-Grade Gliomas.Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
P2860
Q34542656-01A9E5BF-35E8-4253-A165-4AFB7EBE12C8Q35895174-945A8E39-E229-460F-B4C1-C762FBA67E13Q36111620-0F872343-4152-4B07-8573-1D1E990E032DQ38815926-0D274DDC-4880-4C03-9D59-2510DF32F452Q39312420-E3CE5772-39DD-4188-ACFF-1294D0F44DA6Q39852579-400CD173-C4E4-4EE0-BEE8-2CC68D8A2A3EQ48168860-D737D2B9-174F-4074-8336-D877A54CDB4FQ52148215-AA2516F1-D184-4C27-A7D7-5D9114390D81
P2860
Parametric response maps of perfusion MRI may identify recurrent glioblastomas responsive to bevacizumab and irinotecan.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Parametric response maps of pe ...... to bevacizumab and irinotecan.
@ast
Parametric response maps of pe ...... to bevacizumab and irinotecan.
@en
type
label
Parametric response maps of pe ...... to bevacizumab and irinotecan.
@ast
Parametric response maps of pe ...... to bevacizumab and irinotecan.
@en
prefLabel
Parametric response maps of pe ...... to bevacizumab and irinotecan.
@ast
Parametric response maps of pe ...... to bevacizumab and irinotecan.
@en
P2093
P2860
P50
P1433
P1476
Parametric response maps of pe ...... to bevacizumab and irinotecan
@en
P2093
Alessandro Scotti
Anna Luisa Di Stefano
Elena Anghileri
Gaetano Finocchiaro
Lucia Cuppini
P2860
P304
P356
10.1371/JOURNAL.PONE.0090535
P407
P577
2014-03-27T00:00:00Z